Bionano Genomics (BNGO) Current Deferred Revenue (2017 - 2026)
Bionano Genomics recorded quarterly Current Deferred Revenue of $1.1 million in Q1 2026, up 16.44% quarter-over-quarter from $967000.0 in Q4 2025, and up 10.39% year-over-year from $1.0 million in Q1 2025.
Bionano Genomics' Current Deferred Revenue history runs 10 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Current Deferred Revenue rose 10.39% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (up 10.39% YoY), while the FY2025 annual figure was $967000.0, down 14.27% from the prior year.
- Current Deferred Revenue came in at $1.1 million for Q1 2026 at Bionano Genomics, up from $967000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $1.2 million in Q3 2024 to a low of $783000.0 in Q4 2023.
- A 5-year average of $1.0 million and a median of $1.1 million in 2022 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue surged 267.77% in 2022 and slipped 17.12% in 2023, its largest moves.
- Bionano Genomics' Current Deferred Revenue stood at $871000.0 in 2022, then dropped by 10.1% to $783000.0 in 2023, then surged by 44.06% to $1.1 million in 2024, then fell by 14.27% to $967000.0 in 2025, then advanced by 16.44% to $1.1 million in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $1.1 million, $967000.0, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Bionano Genomics | 14.92 Mn | 539,417.67 | 3.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 967,000.00 |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 783,000.00 |
| Sep 30, 2023 | 811,000.00 |
| Jun 30, 2023 | 978,000.00 |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 871,000.00 |
| Sep 30, 2022 | 976,000.00 |
| Jun 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | 684,000.00 |
| Sep 30, 2021 | 411,000.00 |
| Jun 30, 2021 | 445,000.00 |
| Mar 31, 2021 | 301,000.00 |
| Dec 31, 2020 | 416,000.00 |
| Sep 30, 2020 | 412,000.00 |
| Jun 30, 2020 | 289,000.00 |
| Mar 31, 2020 | 318,000.00 |
| Dec 31, 2019 | 357,492.00 |
| Sep 30, 2019 | 417,891.00 |
| Jun 30, 2019 | 421,342.00 |
| Mar 31, 2019 | 213,898.00 |
| Dec 31, 2018 | 270,998.00 |
| Sep 30, 2018 | 335,604.00 |
| Dec 31, 2017 | 211,697.00 |